Ikris PharmaJun 23, 20212 min readMedical uses of PomalidomidePomalidomide specifically is a thalidomide analogue used in the treatment of patients with multiple myeloma who have taken at least a...
Ikris PharmaApr 15, 20213 min readOutcome of Lenalidomide in COVID-19 +Ve Patients With Multiple MyelomaAccording to findings from a study presented during the 2nd European Myeloma Network Meeting held virtually in March, "Mortality rates of...
Ikris PharmaApr 8, 20212 min readFDA Granted Approval of Selinexor Triplet for Refractory/Relapsed Multiple MyelomaOn December 18'th, 2020, the FDA granted approval to selinexor along with bortezomib and dexamethasone in order to treat adult patients...
Ikris PharmaSep 16, 20202 min readDrugs That Holds Tomorrow Of Myeloma PatientsDrug therapy in order to kill the myeloma cells is the main therapy for myeloma patients who need treatment. Some of the drugs which are...
Ikris PharmaJul 23, 20203 min readA complete discussion on CarmustineThe drug is indicated as the palliative therapy as a single agent or in established combination therapy with the several other approved...
Ikris PharmaJun 2, 20203 min readMultiple Myeloma: What Are the Available Treatment Options?Multiple myeloma is a cancer type that forms in plasma cells. In this condition, malignant cells accumulate and produce abnormal...
